A share price of Dexcom Inc [DXCM] is currently trading at $73.92, up 2.51%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The DXCM shares have gain 6.05% over the last week, with a monthly amount glided 11.90%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Dexcom Inc [NASDAQ: DXCM] stock has seen the most recent analyst activity on January 12, 2026, when Barclays downgraded its rating to an Underweight but kept the price target unchanged to $71 for it. Previously, Morgan Stanley upgraded its rating to Overweight on December 02, 2025, and kept the price target unchanged to $75. On November 25, 2025, Evercore ISI initiated with a In-line rating and assigned a price target of $68 on the stock. Oppenheimer downgraded its rating to a Perform. Argus started tracking with a Buy rating for this stock on August 21, 2025, and assigned it a price target of $100. In a note dated June 16, 2025, Truist initiated a Buy rating and provided a target price of $102 on this stock.
Dexcom Inc experienced fluctuations in its stock price throughout the past year between $54.11 and $93.25. Currently, Wall Street analysts expect the stock to reach $84.55 within the next 12 months. Dexcom Inc [NASDAQ: DXCM] shares were valued at $73.92 at the most recent close of the market. An investor can expect a potential return of 14.38% based on the average DXCM price forecast.
Analyzing the DXCM fundamentals
Trailing Twelve Months sales for Dexcom Inc [NASDAQ:DXCM] were 4.52B which represents 21.64% growth. Gross Profit Margin for this corporation currently stands at 0.59% with Operating Profit Margin at 0.17%, Pretax Profit Margin comes in at 0.21%, and Net Profit Margin reading is 0.16%. To continue investigating profitability, this company’s Return on Assets is posted at 0.1, Equity is 0.3 and Total Capital is 0.19. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.92.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Dexcom Inc [NASDAQ:DXCM] is 1.56. Further, the Quick Ratio stands at 1.38, while the Cash Ratio is 0.55. Considering the valuation of this stock, the price to sales ratio is 6.38, the price to book ratio is 10.58 and price to earnings (TTM) ratio is 41.14.
Transactions by insiders
Recent insider trading involved Collins Richard Alexander, Director, that happened on Nov 14 ’25 when 2906.0 shares were sold. Director, Collins Richard Alexander completed a deal on Nov 14 ’25 to buy 2906.0 shares. Meanwhile, Director Heller Bridgette P sold 1012.0 shares on Nov 12 ’25.
